Filing Details

Accession Number:
0001466049-11-000081
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2011-10-03 14:05:39
Reporting Period:
2011-09-20
Filing Date:
2011-10-03
Accepted Time:
2011-10-03 14:05:39
Original Submission Date:
2011-09-22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1322505 Biodel Inc BIOD Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1158132 Arthur J Urciuoli C/O Biodel Inc.
100 Saw Mill Road
Danbury CT 06810
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-09-20 10,000 $1.18 30,000 No 4 P Indirect See Footnote (3)
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote (3)
Footnotes
  1. This transaction was originally reported on September 20, 2011. This amendment corrects the previously listed trasaction code so that the transaction is accurrately reflected as the acquisition of securities in an open market purchase.
  2. This transaction was executed in multiple trades at prices ranging from $ 1.18 to $1.19. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the tranaction was reflected.
  3. The transaction reported in this Form 4 was undertaken by ArcherGroup Investments, Ltd., of which the reporting person is the chairman. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership for the purposes of Section 16 or for any other purpose.